Brief: Vincerx Pharma Reports Second Quarter 2022 Financial Results And Provides A Corporate Update
11/08/2022 21:38
Aug 11 (Reuters) - Vincerx Pharma Inc VINC.O :
* VINCERX PHARMA REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND
PROVIDES A CORPORATE UPDATE
* Q2 LOSS PER SHARE $0.88
* EXPECTED CASH RUNWAY INTO LATE 2024
* QTRLY LOSS PER SHARE $0.88
* Q2 EARNINGS PER SHARE VIEW $-0.80 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX4WtKLx
Further company coverage: VINC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vincerx Pharma
See all newsBrief: Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC
Brief: Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities
Vincerx Pharma Inc reports results for the quarter ended December 31 - Earnings Summary
Vincerx Pharma Inc expected to post a loss of $3.40 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Aditxt, Natgas companies, DocuSign